Enhabit, Inc. (NYSE:EHAB) Stock Holdings Lifted by Point72 Asia Singapore Pte. Ltd.

Point72 Asia Singapore Pte. Ltd. increased its stake in Enhabit, Inc. (NYSE:EHABFree Report) by 484.4% during the third quarter, HoldingsChannel.com reports. The fund owned 69,409 shares of the company’s stock after buying an additional 57,532 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Enhabit were worth $548,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. DekaBank Deutsche Girozentrale boosted its position in shares of Enhabit by 39.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 340,412 shares of the company’s stock valued at $3,861,000 after purchasing an additional 95,488 shares during the period. WINTON GROUP Ltd acquired a new position in shares of Enhabit in the second quarter worth about $955,000. Marshall Wace LLP purchased a new position in shares of Enhabit in the second quarter worth approximately $1,941,000. AREX Capital Management LP raised its holdings in shares of Enhabit by 2.5% during the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock valued at $22,056,000 after acquiring an additional 59,353 shares during the period. Finally, Gladius Capital Management LP purchased a new stake in shares of Enhabit in the 2nd quarter valued at approximately $31,000.

Wall Street Analysts Forecast Growth

Separately, Leerink Partners reiterated a “market perform” rating and set a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. According to data from MarketBeat.com, Enhabit currently has an average rating of “Hold” and an average price target of $9.25.

Get Our Latest Analysis on Enhabit

Enhabit Stock Up 1.7 %

Enhabit stock opened at $7.86 on Tuesday. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. The firm has a market cap of $395.23 million, a PE ratio of -3.39 and a beta of 1.84. The firm’s 50 day moving average price is $7.45 and its two-hundred day moving average price is $8.34.

Enhabit (NYSE:EHABGet Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period last year, the company posted $0.03 earnings per share. On average, research analysts predict that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Enhabit Profile

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Read More

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.